VELCADE/Dexamethasone (Vel/Dex) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM): An Interim Analysis of the IFM 2005-01 Randomized Multicenter Phase III Trial.
暂无分享,去创建一个
D. Esseltine | M. Mohty | G. Marit | T. Facon | J. Harousseau | M. Attal | F. Maloisel | C. Chaleteix | L. Benboubker | D. Caillot | H. Maisonneuve | P. Casassus